DHX9-IN-14
DHX9-IN-14 (161) is a RNA helicase DHX9 inhibitor, with an EC50 of 3.4 μM in DHX9 cellular target engagement. Used in cancer research[1].
Product Specifications
CAS Number
[2973747-90-7]
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dhx9-in-14.html
Solubility
10 mM in DMSO
Smiles
CN1C=C(C=C1C2=NC=C(C=C2F)F)C(NC3=CC(NS(C)(=O)=O)=CC=C3)=O
Molecular Formula
C18H16F2N4O3S
Molecular Weight
406.41
References & Citations
[1]Matthew H. Daniels, et al. Inhibitors of rna helicase dhx9 and uses thereof. Patent WO2023158795.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BS47214-02 100 µL
CREB Regulated Transcription Coactivator 2 Recombinant Rabbit mAb
Ask
View Details MBS6184939-01 0.1 mL
CTNNB1 (Catenin (Cadherin-Associated Protein), beta 1, 88kD, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923) (PE)
Ask
View Details MBS6184939-02 5x 0.1 mL
CTNNB1 (Catenin (Cadherin-Associated Protein), beta 1, 88kD, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923) (PE)
Ask
View Details